cevimeline ophthalmic (BTV100)
/ BioTheraVision
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 23, 2025
Evaluation of BTV100 in Subjects With Dry Eye Disease
(clinicaltrials.gov)
- P2 | N=120 | Recruiting | Sponsor: BioTheraVision, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Dry Eye Disease • Ophthalmology
1 to 1
Of
1
Go to page
1